Nasal application of a naturally processed and presented T cell epitope derived from TCR AV11 protects against adjuvant arthritis

Int Immunol. 2000 Dec;12(12):1715-21. doi: 10.1093/intimm/12.12.1715.

Abstract

Reactivity towards TCR peptides plays an important role in the regulation of several experimental autoimmune diseases. In a previous paper, we showed the TCRAV11 usage by an arthritogenic T cell clone isolated from a rat with adjuvant arthritis (AA). Moreover, we identified three immunogenic peptides in AV11: AV11 24-40, 41-55 and 66-80. In the present study, we show that T cells directed towards all three epitopes are part of the immune repertoire. The strongest delayed-type hypersensitivity (DTH) reaction was observed against the peptide derived from the third framework region, peptide AV11 66-80. DTH reactions to this peptide were detectable in naive rats and increased significantly after AA induction. Interestingly, modulation of the AV11 66-80 T cell response by nasal AV11 66-80 administration resulted in reduced DTH responses and in a strong inhibition of AA. These findings suggest that during the natural course of AA, T cells directed towards the third framework region of AV11 do not have a disease regulatory function, but instead play a role in the deterioration of AA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intranasal
  • Animals
  • Arthritis, Experimental / immunology
  • Arthritis, Experimental / prevention & control*
  • Disease Models, Animal
  • Disease Progression
  • Epitopes / administration & dosage
  • Male
  • Peptide Fragments / administration & dosage
  • Rats
  • Rats, Inbred Lew
  • Receptors, Antigen, T-Cell / administration & dosage*
  • Receptors, Antigen, T-Cell / immunology
  • T-Lymphocytes / physiology
  • Vaccination

Substances

  • Epitopes
  • Peptide Fragments
  • Receptors, Antigen, T-Cell